Impact of Mixing Technologies on Transfection Performance in vivo


September 20, 2022|In News

In cooperation with the team from EVOTEC, LEON performed a study on impact of mixing technologies on transfection performance in vivo.

READ MORE

About LEON

LEON delivers novel, validated and optimized solutions based on nanotechnology that create value for clients and provide better outcomes for patients. The company´s technology expedites API’s (small and large molecules) to deliver enhanced bioavailability, increased solubility and improved stability. LEON also revitalizes forgotten formulations and breathes new life into generics. For general information and enquiries please email info@leon-nanodrugs.com